Rouzier et al developed a nomogram for predicting the probability of a complete pathologic response to preoperative anthracycline chemotherapy. This can help identify patients who are likely to benefit from this therapy. The authors are from University of Texas Houston M.D. Anderson Cancer Center, Institut Gustave Roussy in Villejuif, and Hotel-Dieu in Beirut.
Parameters:
(1) estrogen receptor (ER) status
(2) initial T stage (TNM)
(3) histologic grade
(4) age of the patient in years
(5) number of courses of the anthracycline chemotherapy
Parameter |
Findings |
Points |
estrogen receptor |
positive |
0 |
|
negative |
46 |
T stage |
T0 |
100 |
|
T1 |
75 |
|
T2 |
50 |
|
T3 |
25 |
|
T4 |
0 |
histologic grade |
Grade 1 |
0 |
|
Grade 2 |
49 |
|
Grade 3 |
98 |
number of courses |
3 |
0 |
|
4 |
60 |
points for age =
= (-1.21 * (age in years)) + 91.5
where:
• The maximum age is 75 years, with 0 points. For ages > 75 years 0 points will be assigned.
total score =
=SUM(points for all 5 parameters)
Interpretation:
• minimum score: 0
• maximum score: around 364
Total Score |
Probability of Complete Pathologic Response |
< 163 |
< 5% |
163 - 325 |
(0.001443 * ((points)^2)) - (0.4105 * (points)) + 33.65 |
> 325 |
continue with quadratic formula (51 - 66%) |
Specialty: Hematology Oncology, Surgery, general, Obstetrics & Gynecology